Primary Clear Cell Adenocarcinoma of the Uterine Cervix in a 14-Year-Old Virgin Girl: Case Report.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
11 12 2022
Historique:
received: 28 10 2022
revised: 29 11 2022
accepted: 09 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Cervical cancer is rare in adolescent and pediatric populations, with adenocarcinoma being the most commonly reported. Clear cell adenocarcinoma of the uterine cervix accounts for only 4% of all adenocarcinoma cases, and about two-thirds are associated with intrauterine diethylstilbestrol (DES) exposure. We report the case of a 14-year-old virgin girl who presented with a 1-month-long history of abnormal vaginal bleeding and lower abdominal pain. Transabdominal pelvic ultrasound examination revealed the presence of an irregular, homogeneous cervical mass that was 7 cm in size. Therefore, a magnetic resonance imaging (MRI) scan was performed to establish the origin of the tumor and its relationship to adjacent pelvic organs. Furthermore, a vaginoscopy was performed to identify the tumor, and a cervical biopsy was performed. Immunohistochemical and anatomopathological studies resulted in the diagnosis of non-HPV(Human Papilloma Virus)-related clear cell adenocarcinoma of the cervix. Following the oncological examination, she was admitted for radiotherapy. The patient had no maternal history of DES exposure in utero. Even though the number of cases in the literature is low, most of the virgin girls diagnosed with clear cell adenocarcinoma of the cervix have a fatal prognosis because of the delay in making a correct diagnosis.

Identifiants

pubmed: 36554533
pii: ijerph192416652
doi: 10.3390/ijerph192416652
pmc: PMC9779421
pii:
doi:

Substances chimiques

Diethylstilbestrol 731DCA35BT

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Références

Gynecol Oncol. 2008 Jun;109(3):335-9
pubmed: 18394687
Cancer. 1997 Jun 1;79(11):2229-36
pubmed: 9179071
JCO Precis Oncol. 2020 Nov 2;4:
pubmed: 33283136
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Ugeskr Laeger. 2014 Sep 1;176(36):
pubmed: 25293863
Int J Clin Oncol. 2008 Dec;13(6):552-4
pubmed: 19093185
J Pediatr Surg. 2010 Aug;45(8):E1-5
pubmed: 20713196
J Pediatr Hematol Oncol. 2012 Jul;34(5):e174-6
pubmed: 22713709
Onco Targets Ther. 2014 Jan 09;7:111-6
pubmed: 24470762
J Pediatr Hematol Oncol. 2014 Mar;36(2):e131-3
pubmed: 23669724
BMJ Case Rep. 2017 Mar 16;2017:
pubmed: 28302659
Semin Diagn Pathol. 1997 Nov;14(4):233-9
pubmed: 9383823
Gynecol Oncol. 2005 Apr;97(1):296-300
pubmed: 15790482
Cancer. 1996 Feb 1;77(3):507-13
pubmed: 8630958
Medicine (Baltimore). 2020 Jan;99(5):e18646
pubmed: 32000369
J Clin Oncol. 2009 May 10;27(14):2374-81
pubmed: 19364956
Radiographics. 2020 Oct;40(6):1807-1822
pubmed: 32946322
Gynecol Oncol Rep. 2017 Feb 22;20:34-36
pubmed: 28275694
Ann Transl Med. 2021 Dec;9(23):1747
pubmed: 35071441
Sichuan Da Xue Xue Bao Yi Xue Ban. 2021 May;52(3):534-538
pubmed: 34018378
Gynecol Oncol. 2000 Mar;76(3):331-5
pubmed: 10684706
Singapore Med J. 2016 Aug;57(8):470
pubmed: 27549741
Pediatr Blood Cancer. 2004 Sep;43(3):289-94
pubmed: 15266416
Obstet Gynecol. 2005 Jun;105(6):1405-9
pubmed: 15932836
Obstet Gynecol. 1974 May;43(5):640-4
pubmed: 4822647
Rev Med Inst Mex Seguro Soc. 2012 Sep-Oct;50(5):549-52
pubmed: 23282271
CA Cancer J Clin. 2005 Jul-Aug;55(4):211-28; quiz 263-4
pubmed: 16020423
Cancer. 1995 Nov 1;76(9):1591-600
pubmed: 8635063
Int J Gynecol Cancer. 2011 Jan;21(1):137-40
pubmed: 21178575
N Engl J Med. 1971 Apr 15;284(15):878-81
pubmed: 5549830
Clin Transl Oncol. 2022 Feb;24(2):227-243
pubmed: 34635959
N Engl J Med. 1987 Feb 26;316(9):514-6
pubmed: 3807995
Hum Reprod. 2021 Jan 1;36(1):82-86
pubmed: 33147330
Gynecol Oncol. 1996 Mar;60(3):339-44
pubmed: 8774636
Int J Gynaecol Obstet. 2021 Jul;154(1):150-156
pubmed: 33341962
Int J Gynecol Cancer. 2008 May-Jun;18(3):559-63
pubmed: 17692092
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD002225
pubmed: 16034873
Pediatr Dev Pathol. 2005 Nov-Dec;8(6):690-5
pubmed: 16222478
Int J Clin Oncol. 2003 Dec;8(6):399-404
pubmed: 14663645
Eur J Obstet Gynecol Reprod Biol. 2004 Nov 10;117(1):115-6
pubmed: 15474257
Semin Surg Oncol. 1990;6(6):343-6
pubmed: 2263810

Auteurs

Iuliana Elena Bujor (IE)

Department of Obstetrics and Gynecology, University of Medicine and Pharmacy 'Grigore T. Popa', 700115 Iasi, Romania.

Ludmila Lozneanu (L)

Department of Morpho-Functional Sciences I-Histology, Pathology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

Alexandra Ursache (A)

Department of Obstetrics and Gynecology, University of Medicine and Pharmacy 'Grigore T. Popa', 700115 Iasi, Romania.
Department of Obstetrics and Gynecology, Cuza Vodă Hospital, 700038 Iasi, Romania.

Alexandra Cristofor (A)

Department of Obstetrics and Gynecology, University of Medicine and Pharmacy 'Grigore T. Popa', 700115 Iasi, Romania.

Ana-Maria Scurtu (AM)

Department of Pediatric Surgery, Children's Clinical Hospital "St. Maria", 700309 Iasi, Romania.

Petru Plamadeala (P)

Department of Pathology, Children's Clinical Hospital "St. Maria", 700309 Iasi, Romania.

Roxana Gireada (R)

Department of Obstetrics and Gynecology, University of Medicine and Pharmacy 'Grigore T. Popa', 700115 Iasi, Romania.

Cristina Elena Mandici (CE)

Department of Obstetrics and Gynecology, University of Medicine and Pharmacy 'Grigore T. Popa', 700115 Iasi, Romania.

Marcel Alexandru Găină (MA)

Psychiatry, Department of Medicine III, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

Daniela Roxana Matasariu (DR)

Department of Obstetrics and Gynecology, University of Medicine and Pharmacy 'Grigore T. Popa', 700115 Iasi, Romania.
Department of Obstetrics and Gynecology, Cuza Vodă Hospital, 700038 Iasi, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH